Two health insurers have won — at least temporarily — a bid to remand to state court their lawsuits against GlaxoSmithKline seeking reimbursement for the coverage they provided for their insureds who were injured by the drugmaker’s Avandia diabetes drug and Paxil antidepressant drug.

At issue in the case is whether the health insurance carriers are entitled to get from GSK the names and information identifying their insureds who have sued over GSK products.